+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Beneficial effects of probiotic cholesterol-lowering strain of Enterococcus faecium WEFA23 from infants on diet-induced metabolic syndrome in rats



Beneficial effects of probiotic cholesterol-lowering strain of Enterococcus faecium WEFA23 from infants on diet-induced metabolic syndrome in rats



Journal of Dairy Science 100(3): 1618-1628



The aim of this study was to select probiotic Enterococcus strains that have the potential to improve metabolic syndrome (MS). Ten Enterococcus strains isolated from healthy infants were evaluated for their probiotic properties in vitro, and Enterococcus faecium WEFA23 was selected due to its cholesterol removal ability (1.89 ± 0.07 mg/1010 cfu), highest glycodeoxycholic acid-hydrolase activity (1.86 ± 0.01 U/mg), and strong adhesion capacity to Caco-2 cells (17.90 ± 0.19%). The safety of E. faecium WEFA23 was verified by acute oral administration in mice, and it was found to have no adverse effects on general health status, bacterial translocation, and gut mucosal histology. Moreover, the beneficial effects of E. faecium WEFA23 on high-fat diet-induced MS in rats were investigated, and we found WEFA23 significantly decreased body weight, serum lipid levels (total cholesterol, triacylglycerols, and low-density lipoprotein cholesterol), blood glucose level, and insulin resistance in rats fed with a high-fat diet. This indicated that administration of E. faecium WEFA23 improved almost all key markers of MS, including obesity, hyperlipidemia, hyperglycemia, and insulin resistance. Our results supported E. faecium WEFA23 as a candidate for cholesterol-lowering dairy products and improvement of MS. Our research provided novel insights on Enterococcus as a strategy to combat MS.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 059438523

Download citation: RISBibTeXText

PMID: 28041735

DOI: 10.3168/jds.2016-11870


Related references

Enterococcus faecium WEFA23 from infants lessens high-fat-diet-induced hyperlipidemia via cholesterol 7-alpha-hydroxylase gene by altering the composition of gut microbiota in rats. Journal of Dairy Science 101(9): 7757-7767, 2018

Anti-adhesion of probiotic Enterococcus faecium WEFA23 against five pathogens and the beneficial effect of its S-layer proteins against Listeria monocytogenes. Canadian Journal of Microbiology 65(3): 175-184, 2019

The influence of probiotic Enterococcus faecium strain L5 on the microbiota and cytokines expression in rats with dysbiosis induced by antibiotics. Beneficial Microbes 1(3): 265-270, 2010

One-year application of probiotic strain Enterococcus faecium M-74 decreases serum cholesterol levels. Bratislavske Lekarske Listy 106(2): 67-72, 2005

Dynamics of contamination and persistence of Clostridium difficile in intestinal microbiota in newborn infants during antibiotic therapy and use of probiotic strain enterococcus faecium L3. Antibiotiki i Khimioterapiia 58(11-12): 13-18, 2013

Antiviral effects of a probiotic Enterococcus faecium strain against transmissible gastroenteritis coronavirus. Archives of Virology 158(4): 799-807, 2013

Effects of a probiotic strain of Enterococcus faecium on the rate of natural chlamydia infection in swine. Infection and Immunity 73(7): 4346-4353, 2005

Effects of a probiotic strain of Enterococcus faecium on natural infection rate of Chlamydia in swine. Einfluss eines probiotischen Enterococcus faecium auf die naturliche Infektionsrate von Chlamydien beim Schwein: 90 pp., 2005

First complete genome sequence of a probiotic Enterococcus faecium strain T-110 and its comparative genome analysis with pathogenic and non-pathogenic Enterococcus faecium genomes. Journal of Genetics and Genomics 42(1): 43-46, 2015

Beneficial effects of a red wine polyphenol extract on high-fat diet-induced metabolic syndrome in rats. European Journal of Nutrition 56(4): 1467-1475, 2017

Effects of a probiotic Enterococcus faecium strain supplemented from birth to weaning on diarrhoea patterns and performance of piglets. Journal of Animal Physiology and Animal Nutrition 90(1-2): 25-31, 2006

Probiotic Enterococcus faecium CRL 183 inhibit chemically induced colon cancer in male Wistar rats. European Food Research And Technology8: 2, 231-237, 2008

Selection of potential probiotic lactobacilli for cholesterol-lowering properties and their effect on cholesterol metabolism in rats fed a high-lipid diet. Journal of Dairy Science 95(4): 1645-1654, 2012

Effect of the probiotic Enterococcus faecium NCIMB10415 on cell numbers of total Enterococcus spp., E. faecium and E. faecalis in the intestine of piglets. Current Issues in Intestinal Microbiology 8(1): 1-7, 2007

Characterization of novel exopolysaccharide of Enterococcus faecium WEFA23 from infant and demonstration of its in vitro biological properties. International Journal of Biological Macromolecules 128: 710-717, 2019